Redwood Pharma provides a new update regarding divestment of company assets
June 26, 2024 11:00 amStockholm, June 26, 2024. Redwood Pharma today provides an update on the process for divesting the company’s assets. After contacts... View Article
Stockholm, June 26, 2024. Redwood Pharma today provides an update on the process for divesting the company’s assets. After contacts... View Article
Stockholm, 12 June 2024. Redwood Pharma AB (publ) today provides an update on the process for divesting the company’s assets.... View Article
Stockholm, 23 May 2024. Redwood Pharma AB (publ) announces today that the company is evaluating potential solutions to address its... View Article
Stockholm, May 8, 2024. Redwood Pharma AB (publ) announces today that a poster summarizing the company’s clinical study with the... View Article
Stockholm, May 7, 2024. Redwood Pharma AB (publ) announces today that two international companies have begun due diligence of the... View Article
Stockholm, May 6, 2024. Redwood Pharma AB (publ) announces today that all of the company’s board members have committed to... View Article
Stockholm, February 28, 2024. Redwood Pharma AB (publ) announces today that a poster summarizing the company’s clinical study with the... View Article
Stockholm, December 19, 2023. Redwood Pharma AB (publ) announces today that the company will participate in JP Morgan’s annual Healthcare... View Article
Redwood Pharma AB (publ) today announces a change of Certified Adviser from Erik Penser Bank AB to Carnegie Investment Bank... View Article
Stockholm, November 22, 2023. Redwood Pharma AB (publ) announces today that the company will participate in Nordic Life Science Days,... View Article